BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Airlangga University Hospital signs MOU with Singapore's Icon Cancer Center

As the first hospital in Indonesia to cooperate with Icon Cancer Center, Airlangga University Hospital is supporting the government's efforts to promote he...

April 10, 2023 | News

OrganaBio Delivers RUO & GMP LeukoPAC™ Collections to Singapore

The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM)...

April 10, 2023 | News

Cal State Northridge Partners with Fusion to Modernize Pharmacy

CSUN in March went live with Fusion solution ProPharm, a complete pharmacy management system packed with features, workflows, and functionalities specifica...

April 10, 2023 | News

Chula Develops CAR T-Cell Therapy for Thai Lymphoma Patients

Chulalongkorn University and the Faculty of Medicine, Chulalongkorn University, organized the 17th Chula the Impact on "CAR T-Cell Canc...

April 06, 2023 | News

Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio

Jingsong Wang, MD, PhD, Chairman of Nona Biosciences, said, " By combining our respective expertise in antibody engineering and the disease area, we a...

April 06, 2023 | News

Indivumed becomes Indivumed Therapeutics to advance Precision Oncology with Data and AI

After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics after the acqui...

April 05, 2023 | News

Malaria: The fight to control the world's deadliest mosquito-borne disease

Key facts In 2021, nearly half of the world's population was at risk of malaria. That year, there were an estimated 247 million cases of malari...

April 04, 2023 | Analysis

iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model

According to the company's explanation, bacteriophages have been mainly used for R&D on bacterial infectious diseases, but recently the scope of applic...

April 04, 2023 | News

RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

Autoimmune diseases occur when the body's immune system becomes oversensitive to proteins that are normally harmless, thus triggering a reaction that leads...

April 03, 2023 | News

Ablaze Pharmaceuticals to Develop GPC3 Targeted Therapy for Liver Cancer in China

The proprietary GPC3 targeting peptide is being licensed from RayzeBio pursuant to an existing license agreement. Upon in-license of product candidates by ...

March 31, 2023 | News

bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases

bitBiome, Inc. (Head office: Shinjuku-ku, Tokyo; President: Yuji Suzuki; hereafter 'bitBiome') and Kaken Pharmaceuticals (Head office: Bunkyo-ku,...

March 30, 2023 | News

Thermo Fisher Scientific and Arsenal Biosciences Collaborate for T-Cell Therapy Manufacturing

ArsenalBio recently advanced its lead product candidate into clinical manufacturing of its autologous integrated circuit T cell (ICT) therapy for...

March 29, 2023 | News

Noxopharm Announces Novel mRNA Vaccine Enhancer

Proprietary SOF-VACTM asset with potential to make mRNA vaccines safer, better tolerated by patients and more cost-effective to manufacture Preclin...

March 28, 2023 | News

Thermo Fisher Opens Cell Therapy Facility at UCSF to Advance Breakthrough Therapies.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate adv...

March 28, 2023 | News

Stay Connected